These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27388570)

  • 1. Baseline characteristics and treatment-emergent risk factors associated with cerebrovascular event and death with risperidone in dementia patients.
    Howard R; Costafreda SG; Karcher K; Coppola D; Berlin JA; Hough D
    Br J Psychiatry; 2016 Nov; 209(5):378-384. PubMed ID: 27388570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
    Schneider LS; Dagerman KS; Insel P
    JAMA; 2005 Oct; 294(15):1934-43. PubMed ID: 16234500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do atypical antipsychotics cause stroke?
    Herrmann N; Lanctôt KL
    CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
    Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone for the treatment of neuropsychiatric features in dementia.
    Burns A; De Deyn PP
    Drugs Aging; 2006; 23(11):887-96. PubMed ID: 17109567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
    Rossom RC; Rector TS; Lederle FA; Dysken MW
    J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between risperidone treatment and cerebrovascular adverse events in elderly patients with dementia.
    Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
    J Am Geriatr Soc; 2005 Aug; 53(8):1446-8. PubMed ID: 16078986
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
    Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
    JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.
    Kryzhanovskaya LA; Jeste DV; Young CA; Polzer JP; Roddy TE; Jansen JF; Carlson JL; Cavazzoni PA
    J Clin Psychiatry; 2006 Jun; 67(6):933-45. PubMed ID: 16848653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term mortality risk associated with the use of antipsychotics among 26,940 dementia outpatients: a population-based study.
    Langballe EM; Engdahl B; Nordeng H; Ballard C; Aarsland D; Selbæk G
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):321-31. PubMed ID: 24016844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
    Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial.
    Katz IR; Rupnow M; Kozma C; Schneider L
    Am J Geriatr Psychiatry; 2004; 12(5):499-508. PubMed ID: 15353388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.